These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 27951607)

  • 21. Chronic inflammatory demyelinating polyradiculoneuropathy: a role for haematopoietic stem cell transplantation?
    Kazmi MA; Mahdi-Rogers M; Sanvito L
    Autoimmunity; 2008 Dec; 41(8):611-5. PubMed ID: 18958756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
    Haq RU; Pendlebury WW; Fries TJ; Tandan R
    Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
    Busby M; Donaghy M
    J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune-mediated neuropathies.
    Kieseier BC; Mathey EK; Sommer C; Hartung HP
    Nat Rev Dis Primers; 2018 Oct; 4(1):31. PubMed ID: 30310069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP.
    Sommer C; Koch S; Lammens M; Gabreels-Festen A; Stoll G; Toyka KV
    Neurology; 2005 Dec; 65(12):1924-9. PubMed ID: 16380614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression.
    Hung SKY; Hiew FL; Viswanathan S; Puvanarajah S
    J Peripher Nerv Syst; 2018 Sep; 23(3):183-189. PubMed ID: 30027593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ELectron microscopic abnormality and therapeutic efficacy in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin155 immunoglobulin G4 antibody.
    Kuwahara M; Suzuki H; Oka N; Ogata H; Yanagimoto S; Sadakane S; Fukumoto Y; Yamana M; Yuhara Y; Yoshikawa K; Morikawa M; Kawai S; Okazaki M; Tsujimoto T; Kira JI; Kusunoki S
    Muscle Nerve; 2018 Mar; 57(3):498-502. PubMed ID: 28796305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody- and macrophage-mediated segmental demyelination in chronic inflammatory demyelinating polyneuropathy: clinical, electrophysiological, immunological and pathological correlates.
    Vallat JM; Mathis S; Vegezzi E; Richard L; Duchesne M; Gallouedec G; Corcia P; Magy L; Uncini A; Devaux J
    Eur J Neurol; 2020 Apr; 27(4):692-701. PubMed ID: 31769579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic inflammatory demyelinating polyneuropathy.
    Mathey EK; Pollard JD
    J Neurol Sci; 2013 Oct; 333(1-2):37-42. PubMed ID: 23146613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Can sural nerve biopsy be used to orientate the treatment of chronic inflammatory demyelinating polyneuropathy?].
    Andrade R; González I; Machado A; García A
    Rev Neurol; 2001 Dec 1-15; 33(11):1005-9. PubMed ID: 11785024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immune-mediated neuropathies: indications and value of nerve biopsy].
    Verschueren A
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S58-60. PubMed ID: 18087231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. History, Diagnosis, and Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Dyck PJB; Tracy JA
    Mayo Clin Proc; 2018 Jun; 93(6):777-793. PubMed ID: 29866282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic inflammatory demyelinating polyneuropathy in Waldenström's macroglobulinemia.
    Cassereau J; Letournel F; François S; Dubas F; Nicolas G
    Rev Neurol (Paris); 2011 Apr; 167(4):343-7. PubMed ID: 21429544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fisher syndrome and Bickerstaff brainstem encephalitis].
    Kuwabara S
    Rinsho Shinkeigaku; 2014; 54(12):1056-7. PubMed ID: 25672708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
    Tracy JA; Dyck PJ
    Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coincident membranous glomerulonephritis and chronic inflammatory demyelinating polyradiculoneuropathy: questioning the autoimmunity hypothesis.
    Smyth S; Menkes DL
    Muscle Nerve; 2008 Jan; 37(1):130-5. PubMed ID: 17614320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Topics of chronic inflammatory demyelinating polyradiculoneuropathy--diagnosis and treatment situation in Japan].
    Iijima M
    Rinsho Byori; 2013 May; 61(5):407-13. PubMed ID: 23947179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in the diagnosis, pathogenesis and treatment of CIDP.
    Dalakas MC;
    Nat Rev Neurol; 2011 Aug; 7(9):507-17. PubMed ID: 21844897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immune-mediated neuropathies].
    Stoll G; Reiners K
    Nervenarzt; 2016 Aug; 87(8):887-98. PubMed ID: 27474733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.